Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Virtual Conference on September 18-19, 2024
Rhea-AI Summary
Intelligent Bio Solutions Inc. (Nasdaq: INBS), a pioneer in non-invasive drug testing technology, has announced its participation in the upcoming Sidoti Small-Cap Virtual Conference scheduled for September 18-19, 2024. The company's management team is set to present on Thursday, September 19, 2024, at 2:30 p.m. Eastern Time.
Interested parties can register for the webcast through the provided Zoom link. For those seeking additional information about the conference or wishing to arrange one-on-one meetings with INBS management, contacting a Sidoti representative or reaching out to KCSA Strategic Communications via email at INBS@ksca.com is recommended.
This participation underscores INBS's commitment to engaging with investors and showcasing its innovative solutions in the biotechnology sector.
Positive
- None.
Negative
- None.
NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a leader in non-invasive drug testing technology, today announced that its management team will participate in the Sidoti Small-Cap Virtual Conference being held on September 18-19, 2024.
Presentation Details
Date: Thursday, September 19, 2024
Time: 2:30 p.m. Eastern Time
Registration/Webcast Link: https://sidoti.zoom.us/webinar/register/WN_7jmynN8bTrqwS7q4Aupv7w
For more information about the conference, or to schedule a one-on-one meeting with the INBS management team, please contact your Sidoti representative or email KCSA Strategic Communications at INBS@ksca.com.
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. Additionally, the Company’s biosensor platform has the potential to test for various indications, ranging from immunological conditions to communicable diseases. The Company’s current customer segments include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.
For more information, visit: http://www.ibs.inc/
Company Contact:
Intelligent Bio Solutions Inc.
info@ibs.inc
LinkedIn | Twitter
Investor & Media Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
PH: (212) 896-1254
INBS@kcsa.com
FAQ
When is Intelligent Bio Solutions (INBS) presenting at the Sidoti Small-Cap Virtual Conference?
How can I attend the INBS presentation at the Sidoti Small-Cap Virtual Conference?
What is the date range for the Sidoti Small-Cap Virtual Conference featuring INBS?
How can investors arrange meetings with INBS management during the Sidoti conference?
What is the main focus of Intelligent Bio Solutions (INBS) as mentioned in the press release?
